Also known as qiagen
QIAGEN is a life sciences and molecular diagnostics company headquartered in Hilden, Germany, founded in 1980 and listed here as a corporate investor. Its tagline is Sample to Insight, reflecting products that cover sample preparation through analysis. Its portfolio addresses applications including microbiome research, cancer research and oncology, pharma and biotech, human identification and forensics, digital PCR, next-generation sequencing, enzymes for molecular biology, syndromic testing and tuberculosis testing, along with informatics and data tools. Products named include the QIAcuity digital PCR platform and the QIAsymphony automated nucleic acid extraction system, and the company also offers training courses in sample preparation, dPCR, NGS and bioinformatics.
Browse more corporate investors and other institutional investors by location and type in the LPbacked limited-partner database.
Qiagen is a corporate investor based in Hilden, Germany, managing approximately $5.5B in assets.
Qiagen is headquartered in Hilden, Germany.
Qiagen manages approximately $5.5B in assets under management.
Qiagen was founded in 1980.
Qiagen focuses on Early Stage, Early Stage: Seed, Early Stage: Start-up, Biotechnology, Chemicals, Healthcare, Healthcare IT, Industrials.
Verified contact details, key decision-makers, and investment preferences for Qiagen are available on LPbacked. Create a free account to access them.